These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical data marshalled to treat HIV. Clarke T Nature; 2003 Jun; 423(6942):791. PubMed ID: 12815390 [No Abstract] [Full Text] [Related]
3. Slow accumulation of HIV resistance mutations: implications for resource-limited settings? Stevens WS J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045 [No Abstract] [Full Text] [Related]
4. Resistance patterns analyzed in regional study of HIV patterns. Genotype test is routine for ART-naïve patients. AIDS Alert; 2007 May; 22(5):56. PubMed ID: 17577958 [No Abstract] [Full Text] [Related]
5. Update of the drug resistance mutations in HIV-1: 2004. Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709 [No Abstract] [Full Text] [Related]
6. Accrued HIV evidence turns treatment dogma on its head. Check E Nature; 2003 Aug; 424(6951):866. PubMed ID: 12931150 [No Abstract] [Full Text] [Related]
7. HIV drug resistance and you. Resistance overview. A look at the basics. Munk B Posit Aware; 2006; Spec No():6-9. PubMed ID: 16583502 [No Abstract] [Full Text] [Related]
8. Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA. Hicks CB AIDS Clin Care; 2008 Aug; 20(8):64. PubMed ID: 18814369 [No Abstract] [Full Text] [Related]
9. New insights into HIV resistance testing: nursing guidelines and implications. Kirton CA; Kurtyka D; Sterken DJ J Assoc Nurses AIDS Care; 2007; 18(3):74-86. PubMed ID: 17570302 [TBL] [Abstract][Full Text] [Related]
10. HIV drug resistance testing: an update for the clinician. Rice HL; Zolopa AR AIDS Clin Care; 2001 Oct; 13(10):89-91, 94-6, 100. PubMed ID: 11590921 [No Abstract] [Full Text] [Related]
11. HIV and drug resistance - interpretation and therapeutic progress. Gürtler L Intervirology; 2012; 55(2):77-8. PubMed ID: 22286873 [No Abstract] [Full Text] [Related]
12. Putting resistance to the test. Daar ES Posit Living; 2001 Apr; 10(3):15-6, 43-6. PubMed ID: 11548369 [No Abstract] [Full Text] [Related]
13. Current management challenges in HIV: antiretroviral resistance. Kuritzkes DR; Boyle BA; Gallant JE; Squires KE; Zolopa A AIDS Read; 2003 Mar; 13(3):133-5, 138-42. PubMed ID: 12728868 [TBL] [Abstract][Full Text] [Related]
14. Why HIV drug resistance matters: an overview. Learned J Posit Aware; 2005; 16(5):26-30. PubMed ID: 16220604 [No Abstract] [Full Text] [Related]
15. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement? Uy J; Brooks JT; Baker R; Hoffman M; Moorman A; Novak R; Antivir Ther; 2007; 12(6):957-62. PubMed ID: 17926650 [TBL] [Abstract][Full Text] [Related]
16. Antiretroviral resistance in the developing world. Pillay D J HIV Ther; 2007 Dec; 12(4):95-6. PubMed ID: 18578091 [No Abstract] [Full Text] [Related]
17. 25 years of HIV. Fauci AS Nature; 2008 May; 453(7193):289-90. PubMed ID: 18480799 [No Abstract] [Full Text] [Related]
19. Epidemiology of antiretroviral resistance and impact on treatment outcomes. Cane P J HIV Ther; 2007 Dec; 12(4):82-4. PubMed ID: 18391892 [No Abstract] [Full Text] [Related]
20. The Global HIV Drug Resistance Surveillance Program: a partnership between WHO and IAS. International AIDS Society. Havlir D; Vella S; Hammer S AIDS; 2002 Jul; 16(10):7-9. PubMed ID: 12146462 [No Abstract] [Full Text] [Related] [Next] [New Search]